tiprankstipranks
Psyence Biomedical (PBM)
NASDAQ:PBM
US Market
PBM
Psyence Biomedical
RESEARCH TOOLSreports
Want to see PBM full AI Analyst Report?

Psyence Biomedical (PBM) Ratios

272 Followers

Psyence Biomedical Ratios

PBM's free cash flow for Q3 2023 was C$0.00. For the 2023 fiscal year, PBM's free cash flow was decreased by C$ and operating cash flow was C$0.00. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 11.04 11.04 0.09 0.08
Quick Ratio
 11.04 11.04 0.09 0.08
Cash Ratio
 10.32 10.32 0.06 <0.01
Solvency Ratio
 1.71 1.71 -4.23 0.56
Operating Cash Flow Ratio
 -6.28 -6.28 -0.24 -0.04
Short-Term Operating Cash Flow Coverage
 0.00 0.00 -0.28 -0.76
Net Current Asset Value
C$ 5.97MC$ 5.97MC$ -10.98MC$ -13.07M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 9.23 <0.01
Debt-to-Equity Ratio
 0.00 0.00 -0.95 <0.01
Debt-to-Capital Ratio
 0.00 0.00 -19.91 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.09 1.09 -0.10 1.06
Debt Service Coverage Ratio
 110.61 110.61 -4.87 -1.89
Interest Coverage Ratio
 -395.15 -395.15 -51.98 0.00
Debt to Market Cap
 0.00 0.00 <0.01 <0.01
Interest Debt Per Share
 0.02 0.02 1.61 0.02
Net Debt to EBITDA
 -5.98 -5.98 -0.19 -0.52
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%
EBT Per EBIT
-27.62%-27.62%1859.10%-619.35%
Return on Assets (ROA)
13.83%13.83%-4518.72%3.10%
Return on Equity (ROE)
-47.61%15.05%466.25%3.28%
Return on Capital Employed (ROCE)
-54.49%-54.49%25.08%-0.53%
Return on Invested Capital (ROIC)
-54.49%-54.49%524.51%-0.53%
Return on Tangible Assets
13.83%13.83%-4518.72%3.10%
Earnings Yield
26.51%7.07%-1.31%<0.01%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00
Payables Turnover
 0.02 0.02 <0.01 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 -22.40K -22.40K -855.24K 0.00
Days of Sales Outstanding
 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 22.40K 22.40K 855.24K 0.00
Operating Cycle
 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -6.57 -6.57 -0.45 -0.02
Free Cash Flow Per Share
 -6.59 -6.59 -0.45 -0.02
CapEx Per Share
 0.02 0.02 <0.01 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -378.07 -378.07 -514.29 0.00
Capital Expenditure Coverage Ratio
 -378.07 -378.07 -514.29 0.00
Operating Cash Flow Coverage Ratio
 0.00 0.00 -0.28 -0.76
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-2929.48%-26.16%-0.08%>-0.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 4.44 14.15 -76.24 20.54K
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 0.67 2.13 -355.48 672.82
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.04 -3.82 -1.32K -316.80K
Price-to-Operating Cash Flow Ratio
 -1.20 -3.83 -1.32K -316.80K
Price-to-Earnings Growth (PEG) Ratio
 0.04 -0.12 -0.07 -57.70
Price-to-Fair Value
 0.67 2.13 -355.48 672.82
Enterprise Value Multiple
 -5.84 7.98 -76.51 -127.21K
Enterprise Value
 -6.01M 8.18M 3.91B 164.61B
EV to EBITDA
 -5.86 7.98 -76.51 -127.21K
EV to Sales
 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 1.60 -2.18 -1.33K -316.81K
EV to Operating Cash Flow
 1.61 -2.19 -1.33K -316.81K
Tangible Book Value Per Share
 11.83 11.83 -1.68 7.49
Shareholders’ Equity Per Share
 11.83 11.83 -1.68 7.49
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00
Revenue Per Share
 0.00 0.00 0.00 0.00
Net Income Per Share
 1.78 1.78 -7.85 0.25
Tax Burden
 1.00 1.00 1.00 1.00
Interest Burden
 0.99 0.99 1.00 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00
Income Quality
 -3.69 -3.69 0.06 21.22
Currency in CAD